Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00576524 · ClinicalTrials.gov registry record · Phase 2
Application of Impedance Threshold Device Technologies to Treat and Prevent Hypotension During Dialysis
A Phase 2 study, sponsored by Children's Hospital of Philadelphia.
- Terminated
- Registry status
- Phase 2
- Development phase
- 2
- Enrollment target
NCT00576524 is a Phase 2 study that was terminated before completion, run by Children's Hospital of Philadelphia. The registered enrollment target is 2 participants.
The verdict
NCT00576524, a Phase 2 study, was terminated before completion, sponsored by Children's Hospital of Philadelphia.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the application of the impedance threshold device during hemodialysis in children to optimize fluid removal, reduce the incidence of complications (such as cramps,vomiting and hypotension), and device tolerance.
Interventions
- DEVICE Sham
- DEVICE ITD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-02 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00576524
The ClinicalTrials.gov registry entry for NCT00576524 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT00576524 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00576524 about?
NCT00576524 is a clinical study titled "Application of Impedance Threshold Device Technologies to Treat and Prevent Hypotension During Dialysis". The purpose of this study is to evaluate the application of the impedance threshold device during hemodialysis in children to optimize fluid removal, reduce the incidence of complications (such as cramps,vomiting and hypotension), and device tolerance.
What is the current status of trial NCT00576524?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 2 participants. The study started on 2008-09. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00576524?
The interventions under investigation include: Sham (DEVICE), ITD (DEVICE).
Who is sponsoring clinical trial NCT00576524?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.